comparemela.com
Home
Live Updates
Lack of Efficacy Ends Trial Evaluating Janssen's HIV Vaccine
Lack of Efficacy Ends Trial Evaluating Janssen's HIV Vaccine
Lack of Efficacy Ends Trial Evaluating Janssen's HIV Vaccine Candidate
A phase 3 trial evaluating an investigational HIV vaccine regimen for the prevention of HIV-1 infection will be discontinued.
Related Keywords
,
Janssen Research Development ,
Penny Heaton ,
Global Therapeutic Area Head ,
Janssen Research ,